Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

Weight Loss in Parkinson’s Disease: No Evidence for Role of Small Intestinal Bacterial Overgrowth
DiBaise, John K. , Driver‐Dunckley, Erika , Mehta, Shyamal H. , Hoffman‐Snyder, Charlene , Lin, Tanya, Driver-Dunckley, Erika, Hoffman-Snyder, Charlene, Crowell, Michael D. , Adler, Charles H.

Journal of Parkinson’s Disease | November 26, 2024 | Volume: 8 | Issue: 4 | Pages: 571-581

10.3233/jpd-181386 | PMID 30149465 Get It

Background and Objective: Weight loss and small intestinal bacterial overgrowth (SIBO) are common in Parkinson’s disease (PD). We aimed to study the relationship between weight loss and SIBO in PD. Methods: This was a cross-sectional study with a prospective, interventional component. Consecutive patients seen in the PD clinic who agreed to participate underwent extensive history, movement exam, SIBO breath testing and answered questionnaires. A subset of those in the weight loss group were treated with rifaximin for 14 days and returned 3 months later for an assessment of their weight, GI symptoms, quality of life and SIBO status. All analyses were adjusted for age and disease duration. Results: Fifty-one patients participated in the study; 37 without weight loss and 14 with weight loss. Total energy intake including the distribution of macronutrient intake was similar between groups while physical activity was less in those with weight loss. PD severity scores did not differ between groups; however, PD-specific quality of life scores were significantly worse for the summary index and the subscales of emotional well-being, social support and communication. The prevalence of constipation, dyspepsia and abdominal pain/discomfort was higher in those with weight loss. The prevalence of SIBO was 14% in the weight loss group and was not different between groups. Eight PD patients with weight loss were treated with rifaximin; no significant change in GI symptoms, quality of life or weight was seen 3 months later. Conclusion: Although a number of differences were identified in quality of life and gastrointestinal symptoms between groups with and without weight loss, SIBO was not associated with weight loss in patients with PD. Given the exploratory nature and small number of patients with weight loss, however, further study is suggested.
Exploring the Utility of Carpal Tunnel Biopsy in Amyloidosis: A Current Perspective
Sullivan, Mikaela H. , Brilla, Maria Alejandra Rodríguez , Shin, Alexander Y. , Rodriguez Brilla, Maria Alejandra , Shin, Alexander Y , Klein, Christopher J.

HAND | November 26, 2024 | Volume: 21 | Issue: 2 | Pages: 211-217

10.1177/15589447241298981 | PMID 39588898 Get It

Recent literature has emphasized the role of hand surgeons in screening patients with carpal tunnel syndrome (CTS) for amyloidosis by performing a carpal tunnel synovial biopsy during open carpal tunnel release (CTR). This has led to misconceptions about the diagnostic utility of synovial biopsy and the clinical evaluation of suspected amyloidosis. Controversy over carpal tunnel biopsy is exacerbated by minimally invasive advances in CTR procedures. This current perspective aims to determine the role of carpal tunnel synovial biopsy in amyloidosis and provide an update for hand surgeons regarding the nuances of amyloidosis. We conclude that carpal tunnel synovial biopsy should not be performed without CTS symptoms but only in patients meeting criteria for open CTR such as in those with severe symptoms which have failed nonoperative treatment and minimally invasive procedures are contraindicated. A screening approach for amyloidosis is proposed in patients presenting with CTS symptoms. Despite advances in the understanding, treatment, and diagnosis of amyloidosis, there remains a need for accurate, specific, and sensitive diagnostic tests.
Treatment Options for Coronal Plane Fractures of the Lunate in Kienböck Disease
Dittman, Lauren E. , Munaretto, Nicholas , Lenartowicz, Karina A. , Shin, Alexander Y. , Moran, Steven L. , Kakar, Sanjeev , Tagliero, Lauren E , Lenartowicz, Karina, Shin, Alexander Y , Bishop, Allen, Kakar, Sanjeev , Munaretto, Nicholas , Bishop, Allen T.

HAND | November 26, 2024 | Volume: 21 | Issue: 1 | Pages: 151-158

10.1177/15589447241298722 | PMID 39588834 Get It

Background: The treatment for Kienböck disease varies widely based on the status of the lunate. To date, there is no consensus regarding the optimal treatment for patients with coronal plane fractures of the lunate, or Lichtman Stage IIIC. Therefore, the purpose of this study was to assess whether coronal plane fractures of the lunate in Kienböck disease healed after surgical intervention, and to determine the outcomes after surgical fixation of the lunate compared with treatment with salvage procedures. Methods: A retrospective review of 36 patients with Lichtman IIIC Kienböck disease was conducted. Patients were classified into lunate reconstruction (vascularized bone graft [VBG] or non-VBG) or salvage procedures (proximal row carpectomy [PRC] or limited fusion). Preoperative and postoperative visual analog scale (VAS) pain, range of motion, grip strength, and Mayo Wrist Score (MWS) were analyzed. Radiographs and computed tomographic scans were reviewed for Lichtman stage, fracture location, union, modified carpal height ratio, Stahl index, and radioscaphoid angle. Results: Thirteen patients underwent lunate reconstruction, 13 underwent limited fusion, and 10 underwent PRC. The overall union rate was 45% after lunate reconstruction, with average time to union of 7 months. There were no differences in union rates between VBG and non-VBG. All 3 groups experienced improvement in their postoperative grip strength and MWS. There were no statistically significant differences in preoperative to postoperative changes in clinical outcome measures between the 3 cohorts; however, when we compared lunate reconstruction with all patients who underwent salvage procedures (limited carpal fusion and PRC), we noted the latter had improved functional outcomes ( P = .019). Four patients (31%) in the reconstruction cohort and 2 patients (8%) in the limited carpal fusion group required reoperation at latest follow-up. Conclusions: Union rate of coronal plane fractures in Kienböck disease remains variable. While the proportion of patients requiring reoperation was higher in the reconstruction group, all groups of patients experienced improvement in their clinical outcomes, without a significant difference between cohorts.
Body mass index at birth and early life and colorectal cancer: A two‐sample Mendelian randomization analysis in European and East Asian genetic similarity populations
Papadimitriou, Nikos , Jenab, Mazda, Moreno, Victor, Platz, Elizabeth A., Duijnhoven, Fränzel J.B. van , Pai, Rish K. , Phipps, Amanda I. , Peters, Ulrike , Hughes, David J , Papadimitriou, Nikos , Murphy, Neil , Chen, Zhishan , Brenner, Hermann , Kweon, Sun-Seog , Marchand, Loı̈c Le , Platz, Elizabeth A. , Cheng, Iona C. , Zheng, Wei , Hughes, David J.

Pediatric Obesity | November 26, 2024 | Volume: 20 | Issue: 1 | Pages: No page available

10.1111/ijpo.13186 | PMID 39587448 Get It

SummaryBackgroundVarying obesogenic inherited predisposition in early to later life may differentially impact colorectal cancer (CRC) development. Previous Mendelian randomization (MR) studies, conducted in populations of European genetic similarity, have not observed any significant associations between early life body weight with CRC risk. However, it remains unclear whether body mass index (BMI) at different early lifetime points is causally related with CRC risk in both Europeans and East Asian populations.ObjectivesWe conducted a two‐sample MR study to investigate potential causal relationships between genetically predicted BMI during early life (birth to 8 years old) and at specific periods (birth, transient, early rise and late rise) and CRC risk.MethodsSummary data were obtained from genome‐wide association study (GWAS) of BMI in 28 681 children from the Norwegian Mother, Father and Child Cohort Study (MoBa) study and applied to CRC GWAS data from European and East Asian descent populations (102 893 cases and 485 083 non‐cases).ResultsThere were no significant associations observed between early life BMI and CRC risk in European or East Asian populations. The effect estimates were similar in European studies (odds ratio [OR] per a 1‐standard deviation [SD] increase: 1.01, 95% confidence interval [CI]: 0.95, 1.07) and in East Asians (OR per a 1‐SD increase: 1.02, 95% CI: 0.91, 1.14). Similar nonsignificant associations were found between time of BMI measurement during childhood and cancer‐site‐specific analyses.ConclusionsWe found little evidence of any associations between early life adiposity on later life CRC risk.
Opening invisible wounds
Walker, Laura , Finch, Alexander S. , Carney, J. Aidan, Walker, Laura E , Finch, Alexander, Carney, Jason, Carney, Jason

Academic Emergency Medicine | November 26, 2024 | Volume: 32 | Issue: 4 | Pages: 474-475

10.1111/acem.15054 | PMID 39587390 Get It

Factors Influencing Nasoalveolar Molding Treatment Completion and Noncompletion in Infants with Cleft Lip and Palate
Herrman, Elisa, Dierkhising, Ross , Lee, Sarah K. , Salinas, Thomas , Sarvas, Elise , Viozzi, Christopher F. , Muller, Olivia M. , Herrman, Elisa I , Sarvas, Elise W

The Cleft Palate Craniofacial Journal | November 26, 2024 | Volume: 62 | Issue: 2 | Pages: 214-222

10.1177/10556656241293682 | PMID 39588572 Get It

Objective Identify sociodemographic factors and comorbidities predictive of nasoalveolar molding (NAM) treatment completion and noncompletion in infants with cleft lip with or without (+/–) cleft palate in a rural-suburban population. Design Retrospective cohort study. Setting Tertiary medical center. Patients, Participants Infants diagnosed with cleft lip +/- cleft palate who initiated NAM treatment between 2013 and 2023. Forty-seven patients met inclusion criteria. Main Outcome Measure(s) Prevalence of NAM treatment completion, defined as continued attendance of NAM appointments until initial lip repair surgery. Results NAM treatment noncompletion rate of 23.4%. Noncomplete NAM treatment was associated with greater additional unscheduled NAM visits ( P < .001); increased days inpatient after birth ( P < .001); NICU admission ( P < .001); public insurance ( P = .007); preterm birth ( P = .008); history of social work visits ( P = .024); increased comorbidities ( P = .028); non-Caucasian race ( P = .034); and presence of siblings ( P = .036). Associated comorbidities included use of feeding tube ( P < .001); and conditions related with renal ( P < .001); cardiac ( P = .004); failure to thrive ( P = .009); syndromes ( P = .009); orthopedic ( P = .011); pulmonary ( P = .022); and ophthalmologic systems ( P = .041). Conclusions Increased overall health complexity, public insurance status, and need for social work support were identified as factors associated with NAM noncompletion. These variables can help identify patients at risk of noncompletion and empower providers to supply individualized support and resources.
Current Stroke Solutions Using Artificial Intelligence: A Review of the Literature
Al‐Janabi, Omar , Refaei, Amro El, Elgazzar, Tasnim , Mahmood, Yamama M., Bakir, Danah, Gajjar, Aryan, Alateya, Aysha, Jha, Saroj Kumar , Ghozy, Sherief , Kallmes, David F. , Brinjikji, Waleed , Al-Janabi, Omar M , Ghozy, Sherief , Gajjar, Aryan

Brain Sciences | November 26, 2024 | Volume: 14 | Issue: 12 | Pages: 1182

10.3390/brainsci14121182 | PMID 39766381 Get It

Introduction: In recent years, artificial intelligence (AI) has emerged as a transformative tool for enhancing stroke diagnosis, aiding treatment decision making, and improving overall patient care. Leading AI-driven platforms such as RapidAI, Brainomix®, and Viz.ai have been developed to assist healthcare professionals in the swift and accurate assessment of stroke patients. Methods: Following the PRISMA guidelines, a comprehensive systematic review was conducted using PubMed, Embase, Web of Science, and Scopus. Characteristic descriptive measures were gathered as appropriate from all included studies, including the sensitivity, specificity, accuracy, and comparison of the available tools. Results: A total of 31 studies were included, of which 29 studies focused on detecting acute ischemic stroke (AIS) or large vessel occlusions (LVOs), and 2 studies focused on hemorrhagic strokes. The four main tools used were Viz.ai, RapidAI, Brainomix®, and deep learning modules. Conclusions: AI tools in the treatment of stroke have demonstrated usefulness for diagnosing different stroke types, providing high levels of accuracy and helping to make quicker and more precise clinical judgments.
Diagnosing Allergic Contact Dermatitis Using Deep Learning: Single-Arm, Pragmatic Clinical Trial with an Observer Performance Study to Compare Artificial Intelligence Performance with Human Reader Performance
Carter, Rickey E. , Weston, Alexander D. , Wieczorek, Mikolaj A. , Fahad, Sheikh, Caruso, Maria A., Aristizabal, Miguel, Bruce, Alison J., Hall, Matthew R. , Aristizabal, Miguel A , Hall, Matthew R , Bruce, Charles J. , Carter, Rickey E , Pacheco-Spann, Laura M.

Dermatitis® | November 26, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1089/derm.2024.0302 | PMID 39587877 Get It

Abstract: Background: Allergic contact dermatitis is a common, pruritic, debilitating skin disease, affecting at least 20% of the population. Objective: To prospectively validate a computer vision algorithm across all Fitzpatrick skin types. Methods: Each participant was exposed to 10 allergens. The reference criterion was obtained 5 days after initial patch placement by a board-certified dermatologist. The algorithm processed photographs of the test site obtained on Day 5. Human performance in reading the photographs was also evaluated. Results: A total of 206 evaluable participants [mean age 39 years, 66% (136/206) female, and 47% with Fitzpatrick skin types IV–VI] completed testing. Forty-two percent (87/206) of participants experienced 1 or more allergic reaction resulting in a total of 132 allergic reactions. The model provided high discrimination (AUROC 0.86, 95% CI: 0.82–0.90) and specificity (93%, 95% CI: 92%–94%) but with lower sensitivity (58%, 95% CI: 49%–67%). Human performance interpreting the photographs ranged from providing similar performance to the algorithm to providing superior performance when combined across readers. There were no serious adverse events. Conclusions: The combination of a smartphone capture of patch testing sites with deep learning yielded high discrimination across a diverse sample.
All‐Suture Knotless Suture Anchor Repair of Scapholunate Ligament: The Double‐Pulley Repair
Hassebrock, Jeffrey D. , Hinckley, Nathaniel B. , Kozusko, Steven D. , Freilich, Aaron M. , Dacus, A. Rashard , DeGeorge, Brent R. , Hassebrock, Jeffrey D , Chhabra, Anikar

Arthroscopy Techniques | November 26, 2024 | Volume: 14 | Issue: 4 | Pages: No page available

10.1016/j.eats.2024.103333 | PMID 40453007 Get It

Abstract Symptomatic scapholunate tears are a common traumatic problem in the wrist. This article demonstrates a technique for reducing and stabilizing complete scapholunate tears. The purpose is to provide a detailed description of the technique, highlight potential advantages, and discuss preliminary clinical results. Technique Video video See video under supplementary data.
High prevalence of esophageal motility disorders in patients with rheumatologic diseases
Reddy, Sumana, Patel, Beyla, Dellon, Evan S., Eluri, Swathi , Dellon, Evan S.

Diseases of the Esophagus | November 26, 2024 | Volume: 38 | Issue: 1 | Pages: No page available

10.1093/dote/doae108 | PMID 39586592 Get It

Summary While it is commonly known that patients with rheumatologic diseases can have esophageal dysfunction, this association is insufficiently understood. The aim is to determine the prevalence and characteristics of esophageal motility disorders in patients with rheumatic diseases. This is a single-center retrospective study of adults with rheumatologic disease who underwent high-resolution esophageal manometry (HREM). Those with and without a motility disorder (defined per Chicago classification CCv3.0 criteria, given the timing of the prior studies) were compared and multivariable logistic regression was used to determine odds of motility disorder by rheumatic disease. Of 289 patients, the mean age was 60.5 ± 13.8 years. Rheumatic diseases included Raynaud’s (42%), rheumatoid arthritis (RA) (39%), Sjogren’s (21%), systemic lupus erythematous (19%), systemic sclerosis (17%), and mixed connective tissue disease (13%). On HREM, 58% had an esophageal motility disorder: achalasia (5%), EGJ outflow obstruction (20%), jackhammer (8%), diffuse esophageal spasm (1%), ineffective esophageal motility (28%), and fragmented peristalsis (2%). Of note, 50% of the sample with a normal barium swallow had an esophageal dysmotility disorder on HREM. Those with psoriatic arthritis were less likely to have esophageal dysmotility (73% vs. 27%; P = 0.04). There was decreased odds of esophageal hypocontractility in those with RA (OR [95%CI]: 0.27 [0.12–0.58]) and increased odds (OR [95%CI]: 3.13 [1.16–8.41]) of esophageal hypocontractility among those with scleroderma. Esophageal motor disorders were found in more than half of patients with rheumatologic diseases who underwent HREM. HREM should be considered in patients with rheumatic conditions presenting with esophageal symptoms.